Home Mf Research Whiteoak Capital Pharma And Healthcare Fund Regular Growth

Whiteoak Capital - Pharma And Healthcare Fund - Regular Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
Fund info
NAV (as on 2026-04-07)
₹13.33 0.46%
AUM (Fund Size)
N/A
Expense Ratio
2.37%
Exit load
N/A
Risk
N/A
AMC
WhiteOak Capital Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2026-03-31 ₹1,000.00 ₹995.37
-0.46 %
Two Week 2026-03-23 ₹1,000.00 ₹1,001.50
0.15 %
One Month 2026-03-09 ₹1,000.00 ₹970.44
-2.96 %
Three Months 2026-01-07 ₹3,000.00 ₹2,921.80
-2.61 %
Six Months 2025-10-09 ₹6,000.00 ₹5,786.36
-3.56 %
One Year 2025-04-07 ₹12,000.00 ₹11,874.02
-1.05 %
Since Inception 2024-01-16 ₹28,000.00 ₹30,311.10
8.25 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in Whiteoak Capital - Pharma And Healthcare Fund - Regular Growth

Pharmaceuticals & Biotechnology
57%
Healthcare Services
11%
Healthcare Equipment & Supplies
2%
Chemicals & Petrochemicals
0%
Unknown
13%

Companies Holding in Whiteoak Capital - Pharma And Healthcare Fund - Regular Growth

Sun Pharmaceutical Industries Limited
7.02%
Cipla Limited
4.59%
Divi's Laboratories Limited
4.97%
Zydus Lifesciences Limited
5.36%
Lupin Limited
2.30%
Torrent Pharmaceuticals Limited
4.07%
Dr. Reddy's Laboratories Limited
3.40%
Aurobindo Pharma Limited
3.14%
Emcure Pharmaceuticals Limited
3.24%
Glenmark Pharmaceuticals Limited
3.11%
Ajanta Pharma Limited
3.04%
Max Healthcare Institute Limited
2.78%
Krishna Institute Of Medical Sciences Limited
2.66%
Neuland Laboratories Limited
2.66%
Poly Medicure Limited
2.65%
Fortis Healthcare Limited
2.58%
Vijaya Diagnostic Centre Limited
2.42%
Biocon Limited
2.28%
Piramal Pharma Limited
1.91%
Dr. Lal Path Labs Limited
1.89%
Gland Pharma Limited
1.82%
Shilpa Medicare Limited
1.69%
AstraZeneca Pharma India Limited
1.64%
Wockhardt Limited
1.63%
Ami Organics Limited
1.55%
RPG Life Sciences Limited
1.43%
Jupiter Life Line Hospitals Limited
1.38%
Suven Pharmaceuticals Limited
1.33%
FDC Limited
1.16%
Apollo Hospitals Enterprise Limited
1.11%
Supriya Lifescience Limited
1.08%
Granules India Limited
1.02%
Gufic Biosciences Limited
1.01%
Strides Pharma Science Limited
0.96%
Sanofi Consumer Healthcare India Limited
0.75%
Indegene Limited
0.74%
Innova Captab Limited
0.67%
Neogen Chemicals Limited
0.53%
Mankind Pharma Limited
0.19%
Treasury Bill
2.74%
364 Days Sovereign
1.38%
182 Days Sovereign
1.01%
91 Days Sovereign
0.35%
TREPS
8.31%
Net Receivables / (Payables)
1.19%

Risk Ratios

Std. Deviation N/A
Beta N/A
Sharpe Ratio N/A
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
2.37
Expense Ratio Direct
0.65
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Mr. Ramesh Mantri
Over 20 Years Experience
Mr. Dheeresh Pathak
Over 16 Years Experience
Mr. Piyush Baranwal
Over 14 Years Experience

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?